These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 29198824

  • 1. Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells.
    Ma Y, Cheng Z, Liu J, Torre-Healy L, Lathia JD, Nakano I, Guo Y, Thompson RC, Freeman ML, Wang J.
    Stem Cell Reports; 2017 Dec 12; 9(6):1948-1960. PubMed ID: 29198824
    [Abstract] [Full Text] [Related]

  • 2. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.
    Floyd DH, Kefas B, Seleverstov O, Mykhaylyk O, Dominguez C, Comeau L, Plank C, Purow B.
    Neuro Oncol; 2012 Oct 12; 14(10):1215-26. PubMed ID: 22962413
    [Abstract] [Full Text] [Related]

  • 3. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
    Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG.
    Stem Cells; 2010 Jan 12; 28(1):5-16. PubMed ID: 19904829
    [Abstract] [Full Text] [Related]

  • 4. Notch promotes radioresistance of glioma stem cells.
    Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN, Sullenger BA.
    Stem Cells; 2010 Jan 12; 28(1):17-28. PubMed ID: 19921751
    [Abstract] [Full Text] [Related]

  • 5. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
    Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD, Yuan Y, Sulman EP, Lang FF, Colman H, Verhaak RG, Yung WK, Koul D.
    Stem Cells; 2014 Jan 12; 32(1):301-12. PubMed ID: 24038660
    [Abstract] [Full Text] [Related]

  • 6. Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy.
    Ghanbari-Movahed M, Ghanbari-Movahed Z, Momtaz S, Kilpatrick KL, Farzaei MH, Bishayee A.
    Molecules; 2021 Feb 12; 26(4):. PubMed ID: 33673088
    [Abstract] [Full Text] [Related]

  • 7. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
    BeLow M, Osipo C.
    Cells; 2020 Sep 29; 9(10):. PubMed ID: 33003540
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.
    Yang YP, Chien Y, Chiou GY, Cherng JY, Wang ML, Lo WL, Chang YL, Huang PI, Chen YW, Shih YH, Chen MT, Chiou SH.
    Biomaterials; 2012 Feb 29; 33(5):1462-76. PubMed ID: 22098779
    [Abstract] [Full Text] [Related]

  • 9. The Radiosensitizing Effect of AZD0530 in Glioblastoma and Glioblastoma Stem-Like Cells.
    Yun HS, Lee J, Kil WJ, Kramp TR, Tofilon PJ, Camphausen K.
    Mol Cancer Ther; 2021 Sep 29; 20(9):1672-1679. PubMed ID: 34158343
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme.
    Gersey Z, Osiason AD, Bloom L, Shah S, Thompson JW, Bregy A, Agarwal N, Komotar RJ.
    World Neurosurg; 2019 Nov 29; 131():252-263.e2. PubMed ID: 31376551
    [Abstract] [Full Text] [Related]

  • 11. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M, Kleber S, Röhrich M, Timke C, Han N, Tuettenberg J, Martin-Villalba A, Debus J, Peschke P, Wirkner U, Lahn M, Huber PE.
    Cancer Res; 2011 Dec 01; 71(23):7155-67. PubMed ID: 22006998
    [Abstract] [Full Text] [Related]

  • 12. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J, Mao Z, Huang J, Xie S, Liu T, Mao Z.
    Biochem Biophys Res Commun; 2014 Feb 21; 444(4):670-5. PubMed ID: 24502949
    [Abstract] [Full Text] [Related]

  • 13. z-Leucinyl-leucinyl-norleucinal induces apoptosis of human glioblastoma tumor-initiating cells by proteasome inhibition and mitotic arrest response.
    Monticone M, Biollo E, Fabiano A, Fabbi M, Daga A, Romeo F, Maffei M, Melotti A, Giaretti W, Corte G, Castagnola P.
    Mol Cancer Res; 2009 Nov 21; 7(11):1822-34. PubMed ID: 19861404
    [Abstract] [Full Text] [Related]

  • 14. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
    Cenciarelli C, Marei HE, Zonfrillo M, Pierimarchi P, Paldino E, Casalbore P, Felsani A, Vescovi AL, Maira G, Mangiola A.
    Mol Cancer; 2014 Nov 08; 13():247. PubMed ID: 25380967
    [Abstract] [Full Text] [Related]

  • 15. Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockade.
    Chu Q, Orr BA, Semenkow S, Bar EE, Eberhart CG.
    Clin Cancer Res; 2013 Jun 15; 19(12):3224-33. PubMed ID: 23630166
    [Abstract] [Full Text] [Related]

  • 16. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN, Tian R, Zhang M, Gui ZH, Wu J, Ding M, Zhou XF, He J.
    Oncotarget; 2016 Nov 29; 7(48):78813-78826. PubMed ID: 27705931
    [Abstract] [Full Text] [Related]

  • 17. Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.
    Jung Y, Park H, Zhao HY, Jeon R, Ryu JH, Kim WY.
    Mol Cells; 2014 Jul 29; 37(7):547-53. PubMed ID: 25078449
    [Abstract] [Full Text] [Related]

  • 18. Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.
    Johnson J, Ascierto ML, Mittal S, Newsome D, Kang L, Briggs M, Tanner K, Marincola FM, Berens ME, Vande Woude GF, Xie Q.
    J Transl Med; 2015 Sep 17; 13():306. PubMed ID: 26381735
    [Abstract] [Full Text] [Related]

  • 19. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E, Lang V, Bohlen J, Bethke F, Puccio L, Tichy D, Herold-Mende C, Hielscher T, Lichter P, Goidts V.
    Int J Cancer; 2016 Oct 15; 139(8):1776-87. PubMed ID: 27299852
    [Abstract] [Full Text] [Related]

  • 20. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk.
    Sun T, Patil R, Galstyan A, Klymyshyn D, Ding H, Chesnokova A, Cavenee WK, Furnari FB, Ljubimov VA, Shatalova ES, Wagner S, Li D, Mamelak AN, Bannykh SI, Patil CG, Rudnick JD, Hu J, Grodzinski ZB, Rekechenetskiy A, Falahatian V, Lyubimov AV, Chen YL, Leoh LS, Daniels-Wells TR, Penichet ML, Holler E, Ljubimov AV, Black KL, Ljubimova JY.
    Cancer Res; 2019 Mar 15; 79(6):1239-1251. PubMed ID: 30659021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.